SABES

Status

Ongoing

Phase

Principal Investigator(s)

Ann Duerr

Objective

HOME: a comprehensive HIV testing and linkage package for young MSM of color.

Effect of rapid ART (Atripla) after HIV infection on HIV viral load.

Prevention Option(s)

Treatment

Study Design

Controlled

Randomized

Arms and Assigned Interventions

Description

Immediate ART (Atripla) Daily Atripla will be provided to these patients for the duration of the study beginning at enrollment.

ARMs

Experimental

Description

Deferred ART (Atripla) Daily Atripla will be provided to these patients for the duration of the study beginning at 24 weeks.

ARMs

Placebo Comparator

Official Code

Trial Sponsors

Fred Hutchinson Cancer Research Center

July 2013

December 2016

Enrollment

150

Years

Population

MSM

Sites

Lima

Peru

You are here